Psychiatry and Neurology, Neurology · Washington, DC
NPI
1154328615
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1328 Southern Ave SE
Washington, DC, 20032
Phone (202) 561-8464
Medicare paid, 2024
$52K
482 services
Medicare patients, 2024
149
Average age 71
Drug cost, 2024
$268K
1,736 prescriptions
Company payments, 2025
$33.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taghi Kimyai-Asadi was code 99214 (office e&m - established), 225 times for 98 patients. In total Taghi Kimyai-Asadi billed 482 services in 12 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 225 | 98 | $92.23 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 82 | 32 | $88.27 | $7,238 |
| 95886 Electrical Nerve Conductivity | Office | 32 | 18 | $78.51 | $2,512 |
| 95816 Neurologic | Office | 29 | 25 | $327.57 | $9,499 |
| 99204 Office E&M - New | Office | 27 | 27 | $123.52 | $3,335 |
| 99213 Office E&M - Established | Office | 25 | 13 | $52.51 | $1,313 |
| 99223 Hospital E&M - Initial | Facility | 25 | 25 | $123.14 | $3,078 |
| 95910 Electrical Nerve Conductivity | Office | 19 | 17 | $141.66 | $2,692 |
By year: 2022 $97K for 816 services; 2023 $78K for 693 services; 2024 $52K for 482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Taghi Kimyai-Asadi prescribed most often to Medicare patients was Gabapentin, with 282 prescriptions and refills. In total Taghi Kimyai-Asadi wrote 1,736 Medicare prescriptions that cost $268K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 282 | 554 | 88 | $5,161 |
| Levetiracetam Generic | 235 | 424 | 47 | $7,669 |
| Donepezil Hcl Generic | 101 | 213 | 25 | $2,342 |
| Meloxicam Generic | 89 | 178 | 24 | $375 |
| Escitalopram Oxalate Generic | 73 | 169 | 22 | $772 |
| Trazodone Hcl Generic | 66 | 136 | 16 | $374 |
| Topiramate Generic | 62 | 76 | Under 11 | $464 |
| Oxcarbazepine Generic | 47 | 113 | 15 | $3,403 |
| Lorazepam Generic | 44 | 78 | 15 | $223 |
| Pregabalin Generic | 44 | 98 | 14 | $1,553 |
| Phenytoin Sodium Extended Generic | 39 | 82 | Under 11 | $1,388 |
| Meclizine Hcl Generic | 38 | 60 | 11 | $520 |
| Memantine Hcl Generic | 37 | 83 | 12 | $1,077 |
| Memantine Hcl Er Memantine Hcl | 37 | 87 | Under 11 | $4,153 |
| Primidone Generic | 31 | 62 | Under 11 | $709 |
Brand drugs: 93 claims; generic drugs: 1,619 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Taghi Kimyai-Asadi $33.36 ($33.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $33.36.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $33.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.